clonidine has been researched along with fluvoxamine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Maj, J; Rogóz, Z; Skuza, G; Sowińska, H | 1 |
| Como, PG | 1 |
| Artigas, F; Bel, N | 1 |
| Erkwoh, R; Menges, C; Mrazek, M; Steffes, J; Thelen, B | 1 |
| Bailey, P; Castro, JO; Claude, MM; Corrêa, H; Crocq, MA; Diep, TS; Duval, F; Macher, JP; Tremeau, F | 1 |
| Cornil, C; Dumont, F; Fontaine, E; Machowski, R; Mendlewicz, J; Schittecatte, M; Wilmotte, J | 1 |
| Ahonen, J; Backman, JT; Granfors, MT; Neuvonen, M; Neuvonen, PJ | 1 |
| Doki, K; Homma, M; Hosono, H; Kohda, Y; Momo, K | 1 |
| Henney, HR; Runyan, JD | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Boyce, RD; Gómez-Lumbreras, A; Horn, J; Malone, DC; Tan, MS; Villa-Zapata, L | 1 |
3 review(s) available for clonidine and fluvoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Obsessive-compulsive disorder in Tourette's syndrome.
Topics: Behavior Therapy; Clomipramine; Clonidine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Tourette Syndrome | 1995 |
A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients.
Topics: Chemistry, Pharmaceutical; Ciprofloxacin; Clonidine; Dose-Response Relationship, Drug; Drug Interactions; Fluvoxamine; Humans; Multiple Sclerosis; Muscle Relaxants, Central; Treatment Outcome | 2008 |
2 trial(s) available for clonidine and fluvoxamine
| Article | Year |
|---|---|
Noradrenergic dysfunction and antidepressant treatment response.
Topics: Adrenergic alpha-Agonists; Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clonidine; Depressive Disorder; Female; Fluvoxamine; Human Growth Hormone; Humans; Male; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Radioimmunoassay | 2001 |
Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction.
Topics: Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Clonidine; Cross-Over Studies; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Incompatibility; Drug Interactions; Fluvoxamine; Half-Life; Humans; Male; Muscle Relaxants, Central; Probability; Risk Assessment | 2004 |
11 other study(ies) available for clonidine and fluvoxamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice.
Topics: Aggression; Animals; Antidepressive Agents; Citalopram; Clonidine; Drug Interactions; Fluoxetine; Flupenthixol; Fluvoxamine; Humans; Male; Mice; Oximes; Pizotyline; Propylamines; Stereoisomerism | 1982 |
In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
Topics: Adrenergic Uptake Inhibitors; Animals; Carrier Proteins; Cerebral Cortex; Citalopram; Clonidine; Desipramine; Fluoxetine; Fluvoxamine; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters | 1996 |
[Therapeutic experiences with alcohol-related Korsakoff syndrome].
Topics: Adrenergic alpha-Agonists; Adult; Alcohol Withdrawal Delirium; Alcoholism; Anti-Anxiety Agents; Brain; Clonidine; Drug Therapy, Combination; Fluvoxamine; Humans; Korsakoff Syndrome; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Clonidine; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Mianserin; Mirtazapine; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Sleep, REM | 2002 |
Drug interaction of tizanidine and fluvoxamine.
Topics: Adrenergic alpha-Agonists; Aged; Antidepressive Agents, Second-Generation; Body Temperature; Cerebral Infarction; Clonidine; Drug Interactions; Female; Fluvoxamine; Heart Rate; Humans; Male; Middle Aged; Retrospective Studies | 2004 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS).
Topics: Adverse Drug Reaction Reporting Systems; Ciprofloxacin; Clonidine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Interactions; Female; Fluvoxamine; Humans; Hypotension; Male; Middle Aged; United States; United States Food and Drug Administration | 2022 |